CORT
CORCEPT THERAPEUTICS INC
NASDAQ · Healthcare · Biotechnology · US
$111.62
−1.05%Margins
Gross margin
98.3%
EBITDA margin
3.5%
EBIT margin
0.8%
Net margin
6.6%
FCF margin
12.9%
7.8%
Return on equity
6.2%
Return on assets
0.9%
Return on invested capital
0.98x
Asset turnover
$109.7M
Cash from operations
$2.85
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026